pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4464 |
Genomic Coordinates | chr6: 90312742 - 90312833 |
Description | Homo sapiens miR-4464 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4464 | |||||||||||||||||||||||||||||||||||
Sequence | 12| AAGGUUUGGAUAGAUGCAAUA |32 | |||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SEC24A | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | SEC24 homolog A, COPII coat complex component | ||||||||||||||||||||
Transcript | NM_021982 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SEC24A | |||||||||||||||||||||
3'UTR of SEC24A (miRNA target sites are highlighted) |
>SEC24A|NM_021982|3'UTR 1 ATGAATGAAGAAATTTGACTTATTTTTAAGGAATGTCACGATAGTGCAGAATACCTGGAAATGTGTAATACCTTCTTTTT 81 CTATTATGTTTGTGGACTAATGTGATGATTGAGATGTTCTCACTGTGATTTCAACAACCTATAGCAAATAAAAGACCACA 161 GCAGAGAATCAAACATGCAACTCTGAAATACTGTATTTTTCAAATCAGAATATAGCTACGTATGATTGGATACTTTTTTC 241 TTGCCAATTATGTTTGAGTTGTTATGGATTAAAATAAGAATATTGCAGAGGCAAAGTACATTTTGTAAAATAAAGATTTC 321 TGTGTTCTACATGTATATTTCTCATTTTTAATTTTTCTGAATCTTTGGCTGCTACATTTAAAACCTCACAAACCTAAGTG 401 TTGCAGGGAAGTTACAAATTGATTGGTAGTGATGTTTTTAAAATAAAAACAATGGAAAGTAAATATAATGTAGGAAAACT 481 AGAATTCATTCCCCACACGTGTCTTTTTTTTTTCTTTGTTAAGGGAAAGGATCATGTTGACTAAAACTAAACTAATTCTA 561 GTATAGCTTGAGAAAAATATGAAGAAACACATTCAAGCTTTAAAATCTGTCAGTATTCTTTATGCTTGAAGAACAAAGTC 641 ACTTTGATTTGAAGTGAGAACTATCATTAGGTGGTTTTCTGATTTCCTGATGAAGAGTTGGACATACTGTCTTAATCTAT 721 AGTGAAAAGAATTTGAGCTGTCTTCATAAACACTGGGACTAGCAATGATAATAGGGAGATAAGAAACTTTAATTATCTTG 801 ATCCTTTAAGTGGATTTTATTTGGTGCATTTCTGCTCTGGGTATATAATAAAAGTGGGGGTTTTTGGTGAAATGAGTGAA 881 GAAATGAAAGGTTTCTAAAGTGCTATCCAAATACATCAGTAACATTTTTCTAAGGAGTTTAATTGTTAAATTGGAAGTCA 961 TTCATAAGAAATATTTATGCTTGAATATGAAAATCTATGAAAGCATAAATGCTGCTGTTTGATTTGGTGGATATTAAGAT 1041 TATACACATCCAACATATTAAAGTTATGAAAGAAACTTGACTTCTGAAAATCCTTAAGAGACTGCTTTCTTGATTCAGCT 1121 AGAGAAATATTATAGTCAAAACTATTGAGTGAATTTTGTTTACAAATAGGTAAATTATACATTTGTATATTTAAAGTGCT 1201 GTGACATAGTATCTTTAAGAGTTTGGCTCAGTTTTCACAGATTCATTTTGTCTTAAGAATTTCTTAAATATGTTCATGTA 1281 TAATACTTGATCAAAATATTTTTGGGTTTTTTGTTTTGTTTTAATGGGTTAGAAAATGTTTACAATCTTGGTCTTATATG 1361 ATCACCAATGGAATAGTAACTTCCAGGTTTATATCAATATGAGCTGACTTTAACTGAGTTGTTTGGGATAGGGAAGAAGC 1441 AGTCCCTCTACAGTATACAACTACTGCTTGCCAGCTGGATCAAAATAATCATGTTTTATGAAAATATCTCCCTTAAGCAG 1521 TGTTAAGGTTGGTTTGCAGTGTGTAAGTGGCACATTGAACTGGAAGTTTTCTTGAAAGCTGCTTCATCTATTAAGAAGCA 1601 ATTTTCAAATTGTAGCGAATTATATTATCCCCTCTTTTAAAGAAACAGTCGTTATATGCTGATGTTTCTTAAAATAACTA 1681 AAATGTTCCTCTTAATGTGATTTTAAATGGAGTTATTTGTAGGTCCTTTCTTAGTAGTAAAGAATCTTCTAGAGGGAAAC 1761 ATTTGTGCTTTTAGGGATAATCTTCCTTGTGCCTCACTACATCCCTAAGTGGGTATGACTCTTGTTATTACCACATGCTT 1841 TTTTAGTATATTTCACAAATTTACTTTTAAATATTATTTTAGATACGGTGTAACATGTGCAATTCAGAATAATTTTATAA 1921 CAGGTCATGAAAAACATAACTTTAGTTAGGATTCACAATATTTGTTCTCCACATAATGAGAGAATGAATGAGCCTTTGGA 2001 GATACTGATATAAGGCAATTATTTTTTGCAATGTTGAATGTGTTTTTTAGTTTGATTCTTTTTTTTTCCCCCAATAGGGC 2081 ACTACCTGCCATATCATCTTGTATTACTTTTTGATGTAAAGCGACTAATATTTACACTATGCCATATTTTTTTTAATTAT 2161 AGTTGTAAATTATGAAAGATCCTTGAATTTTCTACAGATCTACAACTACTAATGTAACAGACAAGGGCAATCTTGGTATT 2241 TAAATCTGAGCATGGCAGTTCTACCATAAAAAGTACTCTATTTTTCTAATTTCTAGGATTTTTAAAATAACATTTCTGTA 2321 AGTCTGACATACTAATAGTCACTCAAGCAGTACCATTTATTTTAGTTTGCATATATTTTCACTGTTTTTAATTTAATGTA 2401 TTGAGTCTAATAGACTGTTTTGCAATAATTAGAATAAAGATTTATTTCTTCTAATCAAAGATGCATAACAGCTATTATCT 2481 AGGGGACCACCAAATGTGATTTCAAAATTTTGTTAACTATTACAAATGTAATCCTTATATAGAAATTTTAATTTTGTAAA 2561 GTAGTGTATAATATTGTAATATTAAATTCTTGTTCTTAAATTCAAATATGTATTGATCTTCAATGTGCTGTGTTAAATCT 2641 TGCTTCTCTGAAAAGTTGGAGACAAGATTTGTCTTCCTTTTTACAGTTTGTAATTTTCACTGTTTTATTCCTGTTAAAAA 2721 AAAAAAAAAGTCATTTGTAACCCATGCAGACCATTGTTTGATCTATGCTAACTTATCAACTTGGCTATTCAATAAAGTTA 2801 ATTGAAAAGAGCTTATAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 10802.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000398844.2 | 3UTR | AAUCUUUGGCUGCUACAUUUAAAACCUCACAAACCUAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000398844.2 | 3UTR | AAUCUUUGGCUGCUACAUUUAAAACCUCACAAACCUAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
81 hsa-miR-4464 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT056004 | ARL5B | ADP ribosylation factor like GTPase 5B | 2 | 2 | ||||||||
MIRT061568 | BTG2 | BTG anti-proliferation factor 2 | 2 | 2 | ||||||||
MIRT078651 | ICT1 | mitochondrial ribosomal protein L58 | 2 | 2 | ||||||||
MIRT087551 | YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta | 2 | 4 | ||||||||
MIRT088139 | SEPT2 | septin 2 | 2 | 4 | ||||||||
MIRT095089 | SEC24A | SEC24 homolog A, COPII coat complex component | 2 | 4 | ||||||||
MIRT099065 | FOXC1 | forkhead box C1 | 2 | 4 | ||||||||
MIRT150194 | MIDN | midnolin | 2 | 2 | ||||||||
MIRT178173 | EIF5AL1 | eukaryotic translation initiation factor 5A-like 1 | 2 | 4 | ||||||||
MIRT178942 | C11ORF57 | chromosome 11 open reading frame 57 | 2 | 2 | ||||||||
MIRT188776 | SESN2 | sestrin 2 | 2 | 2 | ||||||||
MIRT267026 | EFHD2 | EF-hand domain family member D2 | 2 | 2 | ||||||||
MIRT307213 | ACVR2B | activin A receptor type 2B | 2 | 2 | ||||||||
MIRT324750 | ACER2 | alkaline ceramidase 2 | 2 | 2 | ||||||||
MIRT442732 | TEAD1 | TEA domain transcription factor 1 | 2 | 2 | ||||||||
MIRT444087 | C12orf73 | chromosome 12 open reading frame 73 | 2 | 2 | ||||||||
MIRT445527 | KLF9 | Kruppel like factor 9 | 2 | 2 | ||||||||
MIRT449604 | INIP | INTS3 and NABP interacting protein | 2 | 2 | ||||||||
MIRT451129 | ZNF99 | zinc finger protein 99 | 2 | 2 | ||||||||
MIRT452271 | RPL30 | ribosomal protein L30 | 2 | 2 | ||||||||
MIRT452486 | DDX4 | DEAD-box helicase 4 | 2 | 2 | ||||||||
MIRT454868 | DNAJC15 | DnaJ heat shock protein family (Hsp40) member C15 | 2 | 6 | ||||||||
MIRT455773 | TSPAN6 | tetraspanin 6 | 2 | 4 | ||||||||
MIRT463844 | WRN | Werner syndrome RecQ like helicase | 2 | 2 | ||||||||
MIRT465036 | TTC39C | tetratricopeptide repeat domain 39C | 2 | 2 | ||||||||
MIRT465176 | TRPV2 | transient receptor potential cation channel subfamily V member 2 | 2 | 4 | ||||||||
MIRT465294 | TRIB3 | tribbles pseudokinase 3 | 2 | 4 | ||||||||
MIRT467931 | SLC16A7 | solute carrier family 16 member 7 | 2 | 2 | ||||||||
MIRT471906 | NUAK2 | NUAK family kinase 2 | 2 | 2 | ||||||||
MIRT472724 | MTUS1 | microtubule associated scaffold protein 1 | 2 | 6 | ||||||||
MIRT479785 | CCND1 | cyclin D1 | 2 | 2 | ||||||||
MIRT482446 | ADM | adrenomedullin | 2 | 10 | ||||||||
MIRT485365 | MYLIP | myosin regulatory light chain interacting protein | 2 | 12 | ||||||||
MIRT498399 | KIF6 | kinesin family member 6 | 2 | 2 | ||||||||
MIRT503202 | ACTB | actin beta | 2 | 6 | ||||||||
MIRT503819 | TMEM242 | transmembrane protein 242 | 2 | 2 | ||||||||
MIRT504706 | ZNF117 | zinc finger protein 117 | 2 | 2 | ||||||||
MIRT507802 | CDKN1B | cyclin dependent kinase inhibitor 1B | 2 | 2 | ||||||||
MIRT509968 | KANSL1L | KAT8 regulatory NSL complex subunit 1 like | 2 | 4 | ||||||||
MIRT517306 | ELF4 | E74 like ETS transcription factor 4 | 2 | 6 | ||||||||
MIRT523900 | ENPP6 | ectonucleotide pyrophosphatase/phosphodiesterase 6 | 2 | 6 | ||||||||
MIRT532018 | NOX5 | NADPH oxidase 5 | 2 | 2 | ||||||||
MIRT535334 | PHACTR2 | phosphatase and actin regulator 2 | 2 | 2 | ||||||||
MIRT536944 | HCN4 | hyperpolarization activated cyclic nucleotide gated potassium channel 4 | 2 | 4 | ||||||||
MIRT539322 | AHSA2 | activator of HSP90 ATPase homolog 2 | 2 | 2 | ||||||||
MIRT540189 | GSTM4 | glutathione S-transferase mu 4 | 2 | 2 | ||||||||
MIRT545015 | ZNF439 | zinc finger protein 439 | 2 | 2 | ||||||||
MIRT545265 | TRIM36 | tripartite motif containing 36 | 2 | 4 | ||||||||
MIRT547230 | PAG1 | phosphoprotein membrane anchor with glycosphingolipid microdomains 1 | 2 | 4 | ||||||||
MIRT548425 | ELOVL5 | ELOVL fatty acid elongase 5 | 2 | 2 | ||||||||
MIRT549910 | ADH4 | alcohol dehydrogenase 4 (class II), pi polypeptide | 2 | 2 | ||||||||
MIRT550185 | TMEM106C | transmembrane protein 106C | 2 | 2 | ||||||||
MIRT550775 | ENOX2 | ecto-NOX disulfide-thiol exchanger 2 | 2 | 4 | ||||||||
MIRT552401 | ZNF487P | zinc finger protein 487 | 1 | 1 | ||||||||
MIRT554782 | RHEBP1 | RHEB pseudogene 1 | 2 | 4 | ||||||||
MIRT557311 | HIF1A | hypoxia inducible factor 1 alpha subunit | 2 | 2 | ||||||||
MIRT558635 | CNNM2 | cyclin and CBS domain divalent metal cation transport mediator 2 | 2 | 2 | ||||||||
MIRT563168 | RPS14 | ribosomal protein S14 | 2 | 2 | ||||||||
MIRT564886 | YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | 2 | 2 | ||||||||
MIRT565778 | SEPHS1 | selenophosphate synthetase 1 | 2 | 2 | ||||||||
MIRT566480 | PDCD4 | programmed cell death 4 | 2 | 2 | ||||||||
MIRT567206 | IGFBP5 | insulin like growth factor binding protein 5 | 2 | 2 | ||||||||
MIRT568931 | SMCR8 | Smith-Magenis syndrome chromosome region, candidate 8 | 2 | 2 | ||||||||
MIRT570698 | FBXO41 | F-box protein 41 | 2 | 2 | ||||||||
MIRT573474 | MTRNR2L9 | MT-RNR2-like 9 | 2 | 2 | ||||||||
MIRT576170 | Hmox1 | heme oxygenase 1 | 2 | 2 | ||||||||
MIRT607555 | GLI2 | GLI family zinc finger 2 | 2 | 2 | ||||||||
MIRT608203 | ERBB2 | erb-b2 receptor tyrosine kinase 2 | 2 | 2 | ||||||||
MIRT609779 | VWC2L | von Willebrand factor C domain containing protein 2 like | 2 | 4 | ||||||||
MIRT616312 | CELF2 | CUGBP Elav-like family member 2 | 2 | 2 | ||||||||
MIRT617190 | CDH13 | cadherin 13 | 2 | 2 | ||||||||
MIRT626842 | RPLP1 | ribosomal protein lateral stalk subunit P1 | 2 | 2 | ||||||||
MIRT636438 | MARCH1 | membrane associated ring-CH-type finger 1 | 2 | 2 | ||||||||
MIRT639101 | GLIPR1L2 | GLI pathogenesis related 1 like 2 | 2 | 2 | ||||||||
MIRT691018 | CRTC3 | CREB regulated transcription coactivator 3 | 2 | 2 | ||||||||
MIRT700008 | RPS21 | ribosomal protein S21 | 2 | 2 | ||||||||
MIRT701144 | PANK1 | pantothenate kinase 1 | 2 | 2 | ||||||||
MIRT712691 | NUDT7 | nudix hydrolase 7 | 2 | 2 | ||||||||
MIRT715505 | MAZ | MYC associated zinc finger protein | 2 | 2 | ||||||||
MIRT722509 | PTPRC | protein tyrosine phosphatase, receptor type C | 2 | 2 | ||||||||
MIRT724982 | TNS1 | tensin 1 | 2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|